FR0000120271 - Common Stock
2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue YoY % growth | 184.634B 54.24% | 263.31B 42.61% | 218.945B -16.85% | 239.322B 9.31% | N/A | N/A | N/A | ||||
EBITDA YoY % growth | 38.177B 37.47% | 60.912B 59.55% | 47.249B -22.43% | 45.859B -2.94% | |||||||
EBIT YoY % growth | 23.834B 385.32% | 47.232B 98.17% | 33.431B -29.22% | 32.51B -2.75% | |||||||
Operating Margin | 12.91% | 17.94% | 15.27% | 13.58% | N/A | N/A | N/A | ||||
EPS YoY % growth | 6.68 358.16% | 13.95 108.83% | 9.41 -32.54% | 9.13 -2.94% |
All data in USD
Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS Q2Q % growth | 2.10 -19.37% | |||||||||||
Revenue Q2Q % growth | 61.058B 4.71% | |||||||||||
EBITDA Q2Q % growth | 12.163B | |||||||||||
EBIT Q2Q % growth | 7.771B -21.49% |
All data in USD
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q4 2023 Q2Q % growth | 2.16 -27.27% | 2.30 | -0.14 | -6.08% |
Q3 2023 Q2Q % growth | 2.65 -30.81% | 2.58 | 0.07 | 2.85% |
Q2 2023 Q2Q % growth | 1.99 -46.93% | 2.15 | -0.16 | -7.54% |
Q1 2023 Q2Q % growth | 2.61 -23.24% | 2.57 | 0.04 | 1.48% |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q4 2023 Q2Q % growth | 54.765B -14.37% | 42.215B | 12.55B | 29.73% |
Q3 2023 Q2Q % growth | 54.413B -16.24% | 56.132B | -1.719B | -3.06% |
Q2 2023 Q2Q % growth | 51.458B -26.95% | 53.291B | -1.833B | -3.44% |
Q1 2023 Q2Q % growth | 58.309B -8.82% | 63.942B | -5.633B | -8.81% |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | -0.7% | -11.87% | -0.24% | -7.82% |
Revenue | 4.19% | 20.58% | -0.77% | -4.05% |